Stock listing
Modus Therapeutics Holding Ab
Selected listing: MODTX · OMXSTO · SEK · SE
Modus Therapeutics Holding Ab (Stockholm:MODTX), Health Technology. Latest release May 26, 2026: Modus Therapeutics publishes interim report for Q1 2026.
- Ticker
- Stockholm:MODTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
About Modus Therapeutics Holding Ab
Modus Therapeutics Holding Ab is a public company listed under the ticker MODTX on the Swedish market. Modus Therapeutics focuses on developing innovative therapies, although specific product details and financial performance are not provided.
Latest news from Modus Therapeutics Holding Ab
Modus Therapeutics publishes interim report for Q1 2026
May 26, 2026
Modus announces outcome of exercise of warrants of series TO 2026 and receives approximately SEK 9.5 million
April 27, 2026
Modus Therapeutics Holding AB (publ) publishes annual report for the financial year 2025
April 15, 2026
Modus Therapeutics publishes year-end report for 2025
February 25, 2026
Modus Therapeutics publishes Interim report for the third quarter 2025
November 26, 2025
Events
Replays
Modus Therapeutics Holding AB (publ) (MODTX) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 03:00 AM ET
WatchModus Therapeutics Holding AB (publ) (MODTX) Q3 2025 Earnings Call
Wed, Nov 26, 2025 · 02:00 AM ET
WatchModus Therapeutics Holding AB (publ) (MODTX) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 02:00 AM ET
Watch
Research Modus Therapeutics Holding Ab
Modus Therapeutics Holding Ab company profile
View the public company page for Modus Therapeutics Holding Ab on 6ix.
Modus Therapeutics Holding Ab news
Read company news and market updates connected to Modus Therapeutics Holding Ab.
Modus Therapeutics Holding Ab investor events
Find investor webinars, events, and replay context for Modus Therapeutics Holding Ab.